BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23652159)

  • 1. The experience of long-term opiate maintenance treatment and reported barriers to recovery: a qualitative systematic review.
    Notley C; Blyth A; Maskrey V; Craig J; Holland R
    Eur Addict Res; 2013; 19(6):287-98. PubMed ID: 23652159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Concepts of Abstinence and Recovery Through the Experiences of Long-Term Opiate Substitution Clients.
    Notley C; Blyth A; Maskrey V; Pinto H; Holland R
    Subst Abus; 2015; 36(2):232-9. PubMed ID: 25127184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-assisted treatment of opiate dependence is gaining favor.
    Jerry JM; Collins GB
    Cleve Clin J Med; 2013 Jun; 80(6):345-9. PubMed ID: 23733899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-morbid pain and opioid addiction: long term effect of opioid maintenance on acute pain.
    Wachholtz A; Gonzalez G
    Drug Alcohol Depend; 2014 Dec; 145():143-9. PubMed ID: 25456326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the Chinese police in methadone maintenance therapy: a literature review.
    Meng J; Burris S
    Int J Drug Policy; 2013 Nov; 24(6):e25-34. PubMed ID: 23623719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methadone maintenance patients show a selective deficit to reverse positive outcomes in drug-related conditions compared to medication free prolonged opiate abstinence.
    Levy-Gigi E; Kéri S; Shapiro AR; Sason A; Adelson M; Peles E
    Drug Alcohol Depend; 2014 Nov; 144():111-8. PubMed ID: 25220895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
    Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations.
    Jiang H; Su H; Zhang C; Liu X; Li R; Zhong N; Zhao M
    Eur Neuropsychopharmacol; 2020 Jun; 35():136-137. PubMed ID: 32307223
    [No Abstract]   [Full Text] [Related]  

  • 10. Medication-assisted recovery from opioid addiction: historical and contemporary perspectives.
    White WL
    J Addict Dis; 2012; 31(3):199-206. PubMed ID: 22873182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the Brief Pain Inventory in Patients with Opioid Addiction Receiving Methadone Maintenance Treatment.
    Dennis BB; Roshanov PS; Bawor M; Paul J; Varenbut M; Daiter J; Plater C; Pare G; Marsh DC; Worster A; Desai D; Thabane L; Samaan Z
    Pain Physician; 2016 Jan; 19(1):E181-95. PubMed ID: 26752486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pain management strategies for patients on methadone maintenance therapy: a systematic review of the literature.
    Taveros MC; Chuang EJ
    BMJ Support Palliat Care; 2017 Dec; 7(4):383-389. PubMed ID: 27566722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Perspective on Opioid Pharmacotherapy: Where We Are and How We Got Here.
    Ling W
    J Neuroimmune Pharmacol; 2016 Sep; 11(3):394-400. PubMed ID: 27008037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substance, structure and stigma: parents in the UK accounting for opioid substitution therapy during the antenatal and postnatal periods.
    Chandler A; Whittaker A; Cunningham-Burley S; Williams N; McGorm K; Mathews G
    Int J Drug Policy; 2013 Nov; 24(6):e35-42. PubMed ID: 23688832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neonatal outcomes following in utero exposure to methadone or buprenorphine: a National Cohort Study of opioid-agonist treatment of Pregnant Women in Norway from 1996 to 2009.
    Welle-Strand GK; Skurtveit S; Jones HE; Waal H; Bakstad B; Bjarkø L; Ravndal E
    Drug Alcohol Depend; 2013 Jan; 127(1-3):200-6. PubMed ID: 22841456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of opioid use disorder in an innovative community-based setting after multiple treatment attempts in a woman with untreated HIV.
    Voon P; Joe R; Fairgrieve C; Ahamad K
    BMJ Case Rep; 2016 Jul; 2016():. PubMed ID: 27402654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising treatment in opioid dependency in primary care: results from a national key stakeholder and expert focus group in Ireland.
    Van Hout MC; Crowley D; McBride A; Delargy I
    BMC Fam Pract; 2018 Jun; 19(1):103. PubMed ID: 29960593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An ageing methadone population: A challenge for treating doctors.
    Nagarajan S; Wong A; Greene SL; Koutsogiannis Z
    Aust J Gen Pract; 2019 Mar; 48(3):111-112. PubMed ID: 31256476
    [No Abstract]   [Full Text] [Related]  

  • 19. Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
    Soyka M; Strehle J; Rehm J; Bühringer G; Wittchen HU
    Eur Addict Res; 2017; 23(2):97-105. PubMed ID: 28376505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Categorising methadone: Addiction and analgesia.
    Keane H
    Int J Drug Policy; 2013 Nov; 24(6):e18-24. PubMed ID: 23768774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.